Retrospective real-world research study on multiple myeloma therapy in China CONTEXT: This abstract with reference to full article originally published in Leuk Lymphoma Journal is a retrospective analysis of newly Continue Reading
Retrospective review of healthcare costs associated with treatment-resistant depression (TRD) in Italy CONTEXT: Published in the ClinicoEconomics and Outcomes Research Journal, this retrospective review of around 6 million administrative database Continue Reading
CBD-Rich cannabis products associated with improvements for patients with severe pain, anxiety and depression. CONTEXT: Publication of a real-world evidence study in the Journal of Cannabis Research points to improvements Continue Reading
French researchers first exposure to decentralised trials CONTEXT: Discussion article on one French company’s first experience with the concept of decentralised clinical trials and how they went about solving the Continue Reading
Real-World Research shows comparative risk for mAbs used in severe asthma patients CONTEXT: According to the findings of a real-world research study published in Clinical and Translational Allergy, patients receiving Continue Reading
Lenvatinib superior to sorafenib in patients with unresectable hepatocellular carcinoma CONTEXT: Results from a poster presentation at the World Congress on Gastrointestinal Cancer showed lenvatinib was superior to sorafenib as Continue Reading
Hungarian real-world research study confirms tolerability of palbociclib similar to registration trials in breast cancer patients. CONTEXT: A retrospective review of 962 Hungarian breast cancer patients published in OncoTargets and Continue Reading
Prospective observational study of clozapine in the treatment of schizophrenia. CONTEXT: 189 patients were included in this 5-year prospective observational study which looked at the safety and tolerability profile when Continue Reading
First data from EMPRISE Real-World Evidence study in type 2 diabetes reveals risk reduction for patient on Empagliflozin compared to DPP-4 inhibitors CONTEXT: Interim analysis of the EMPRISE real-world evidence Continue Reading
Symdeko (tezacaftor/ivacaftor) shows favourable results in Scottish real-world evidence study in cystic fibrosis CONTEXT: Publication of a real-world research study in cystic fibrosis in the European Journal of Hospital Pharmacy Continue Reading
